Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 92
Filtrar
1.
Mem. Inst. Oswaldo Cruz ; 107(supl.1): 90-94, Dec. 2012. ilus, mapas, tab
Artigo em Inglês | LILACS | ID: lil-659746

RESUMO

Leprosy is a slowly evolving disease that occurs mainly in adults. In this study, the Mamaría Village, state of Portuguesa was selected because it had one of the highest prevalence rates (13.25%) of leprosy cases in 1997. Between 1998-2004, 20.2% of the 89 cases registered in this village were less than 15 years old and 61.8% were males. Pau-cibacillary (PB) lesions were the predominant clinical forms identified, although also multibacillary (MB) forms were found. Additionally, 76% of the patients were bacteriologically negative. At the time of diagnosis, 75% of the patients presented with grade 0 disabilities, 23% with grade 1 and 2% with grade 2. Serum samples were collected from 18 PB and 15 MB patients, in addition to 14 family contacts, at the beginning and end of treatment. All the groups were re-evaluated during a three-year period (2008-2011). The proteins used for evaluation were ML0405, ML2331 and LID-1. These mycobacterial proteins were highly specific for Mycobacterium leprae and the IgG responses decreased in both MB and PB patients during multidrug treatment. Our results suggest that these antigens could be used as markers for successful treatment of non-reactional lepromatous patients.


Assuntos
Adolescente , Adulto , Feminino , Humanos , Masculino , Adulto Jovem , Proteínas de Bactérias/sangue , Imunoglobulina G/sangue , Hanseníase Multibacilar/diagnóstico , Hanseníase Paucibacilar/diagnóstico , Mycobacterium leprae/imunologia , Anticorpos Antibacterianos/sangue , Proteínas de Bactérias/imunologia , Hanseníase Multibacilar/epidemiologia , Hanseníase Paucibacilar/epidemiologia , Proteínas Recombinantes/sangue , Proteínas Recombinantes/imunologia , Venezuela/epidemiologia
2.
Int J Dermatol ; 51(2): 186-94, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22250629

RESUMO

BACKGROUND: Leprosy is a chronic infectious disease produced by Mycobacterium leprae. In 1997 Venezuela reached the goal of elimination of leprosy as a public health problem (according to the World Health Organization a prevalence rate of ≤ 1/10,000 inhabitants), but five states still had prevalence rates over that goal. For this study we selected Cojedes State, where prevalence rates remain over the elimination goal. OBJECTIVE: Evaluate the real leprosy situation in high-prevalence areas of Cojedes State. MATERIALS AND METHODS: Seven communities of Cojedes State were selected because they had the highest historic prevalence, as well as the highest prevalence in the year to be studied (1997). RESULTS: A rank correlation using Spearman's test comparing historical prevalence rates (1946-1996) and detection rates (1998-2004) gave a statistically significant P < 0.05 value. Diagnosed leprosy cases were as follows: age: 3.2% under 15 years old; sex: male/female rates between 60% and 91.66% males. The highest number of cases were paucibacillary forms: indeterminate leprosy (33.07%) and borderline tuberculoid leprosy (32.28%); tuberculoid leprosy (7.00%); and multibacillary cases (lepromatous leprosy, LL) were only 2.36%. Bacteriologically, 18.52 patients were M. leprae positive. At the moment of diagnosis, 96.6% showed no disabilities, 3.4% showed grade I disabilities, and there were no grade II or III disabilities. CONCLUSION: This study confirms that several communities in Cojedes State have extremely high leprosy rates.


Assuntos
Doenças Endêmicas , Hanseníase/epidemiologia , Feminino , Humanos , Hanseníase/diagnóstico , Masculino , Prevalência , Sistema de Registros , Venezuela/epidemiologia
3.
Mem Inst Oswaldo Cruz ; 107 Suppl 1: 90-4, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23283459

RESUMO

Leprosy is a slowly evolving disease that occurs mainly in adults. In this study, the Mamaría Village, state of Portuguesa was selected because it had one of the highest prevalence rates (13.25%) of leprosy cases in 1997. Between 1998-2004, 20.2% of the 89 cases registered in this village were less than 15 years old and 61.8% were males. Paucibacillary (PB) lesions were the predominant clinical forms identified, although also multibacillary (MB) forms were found. Additionally, 76% of the patients were bacteriologically negative. At the time of diagnosis, 75% of the patients presented with grade 0 disabilities, 23% with grade 1 and 2% with grade 2. Serum samples were collected from 18 PB and 15 MB patients, in addition to 14 family contacts, at the beginning and end of treatment. All the groups were re-evaluated during a three-year period (2008-2011). The proteins used for evaluation were ML0405, ML2331 and LID-1. These mycobacterial proteins were highly specific for Mycobacterium leprae and the IgG responses decreased in both MB and PB patients during multidrug treatment. Our results suggest that these antigens could be used as markers for successful treatment of non-reactional lepromatous patients.


Assuntos
Proteínas de Bactérias/sangue , Imunoglobulina G/sangue , Hanseníase Multibacilar/diagnóstico , Hanseníase Paucibacilar/diagnóstico , Mycobacterium leprae/imunologia , Adolescente , Adulto , Anticorpos Antibacterianos/sangue , Proteínas de Bactérias/imunologia , Feminino , Humanos , Hanseníase Multibacilar/epidemiologia , Hanseníase Paucibacilar/epidemiologia , Masculino , Proteínas Recombinantes/sangue , Proteínas Recombinantes/imunologia , Venezuela/epidemiologia , Adulto Jovem
4.
Fontilles, Rev. leprol ; 28(1): 23-40, ene.-abr. 2011. tab, graf
Artigo em Espanhol | IBECS | ID: ibc-101069

RESUMO

Se diseñó un estudio para evaluar la reactividad inmunológica frente a diferentes preparaciones proteicas micobacterianas utilizando pruebas serológicas y de inmunidad celular. Para el estudio fueron incluidos pacientes con manifestaciones clínicas de lepra predominantemente de la forma multibacilar. El 58% correspondía a la forma clínica de Lepra Lepromatosa (LL) n=81, el 29% a la forma Borderline Lepromatosa (BL) n=41 y 10% a Borderline Bordeline (BB) n=14. Sólo el 3% fueron pacientes Borderline Tuberculoide (BT): 74% masculino y 26% femenino. El fenómeno reaccional más frecuente fue de tipo eritema nodoso leproso (ENL). Las proteínas micobacterianas ensayadas fueron: antígenos proteicos crudos totales de Mycobacterium leprae (MISA), Mycobacterium bovis (MbSA y MbSA de excreción), antígeno proteico de excreción parcialmente purificado con una movilidad relativa de 30 kDa (MI30) y proteínas recombinantes de Mycobacterium (Mt70, Mb 65, MI 36, 28, 18 y 10 KDa) encontrándose que las proteínas recombinantes (MI 10KDa, MI36 kDa) a mayor carga bacilar presentaban una mayor reactividad serológica estadísticamente significativa (p=0.0051 y 0.050 respectivamente). La proteína de 30 kDa) a mayor carga bacilar presentaban una mayor reactividad serológica estadísticamente significativa (p=0.0051 y 0.0050 respectivamente). La proteína de 30 kDa fue predominantemente reconocida por anticuerpos de los pacientes multibacilares. Los resultados demuestran que el promedio de los valores de anticuerpos en pacientes no reaccionales fueron superiores en presencia de proteínas completas (MbSA y MbSA de exreción) en comparación con el grupo de pacientes que presentaron fenómenos reaccionales (p=0.000567 y 0.000061 respectivamente). Este mismo comportamiento se observó frente a las proteínas micobacterianas individuales (30kDA, 10kDa y 36 kDa). La respuesta proliferativa de los linfocitos T en los pacientes multibacilares reaccionales y no reaccionales frente a las proteínas micobacterianas (MISA, ML 10kDa, MbSA, MbSA de excreción) fue negativa en ambos grupos (AU)


The study was designed for evaluating immunological reactivity to various mycobacterial protein preparations using serological and cell-mediated immunological test in patients with clinical leprosy signs, predominantly, with the multibacillary forms. Al patients wer adults with ages between 20 and 39 years. Fifty eight (n=81) percent corresponded to Lepromatous Leprsy (LL), 29% (n=41) to Borderline Lepromatuous Leprosy (BL) and 10% (n=14) to Borderline Borderline Leprosy (BB); only 3% were Bordeline Tuberculoid (BT) patients: 74% males and 26% females. The most frequent reactional phenomenon was of the Erythema Nodosum (ENL) type. The mycobacterial proteins tested were: total crude Mycobacterium leprae antigens (MISA); Mycobacterium bovis (MbSA and excretion MbSA); partially purified excretion protein antigen, with a 30KDa relative movility (Ml30); and recombinant M. leprae protein (Mt70, Mb 65, Ml36, 28, 18 and 10kDa). Two of the recombinant proteints (M110 and Ml36 kDA) presented a statiseally significant higher serological reactivity, directly related with a larger bacillary load (p=0.0051 and 0.050 respectively). The 30kDa protein was predominantly recognized by antibodies from multibacillary patients. Results show that mean antibody values were higher in non reactional patients when tested against complete proteins (MbSA and ex MbSA) when compared with the group of patients who presented reactional phenomena (p=0.000567 and 0.000061, respectively). Comparing reactional with non reactional patients, it was seen that mean antibody values against complete proteins (MbSA and ex MbSA) were higher in non reactional individual (p=0.000567 and 0.000061, respectively). This same behavior occurred towards individual mycobacyterial proteins (30, 10 and 36 kDa). The T lymphocyte prolyphetative response in reactional and non reactional patients towards mycobacterial proteins (MISA, Ml 10 kDA, MbSA, ex MbSA) was negative (AU)


Assuntos
Humanos , Hanseníase Multibacilar/microbiologia , Mycobacterium leprae/isolamento & purificação , Testes Sorológicos/métodos , Proteínas Recombinantes , Hanseníase Virchowiana/epidemiologia , Hanseníase Tuberculoide/epidemiologia , Eritema Nodoso/epidemiologia
5.
Invest. clín ; 51(3): 325-340, Sept. 2010. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-574454

RESUMO

Se diseñó un estudio para evaluar la reactividad inmunológica frente a diferentes preparaciones proteicas micobacterianas utilizando pruebas serológicas y de inmunidad celular. Para el estudio fueron incluídos pacientes con manifestaciones clínicas de lepra predominantemente de la forma multibacilar. Todos los pacientes fueron adultos con edad comprendida entre 20 y 39 años. El 58 por ciento correspondía a la forma clínica de Lepra Lepromatosa (LL) n= 81, el 29 por ciento a la forma Borderline Lepromatosa (BL) n=41 y 10 por ciento a Borderline Borderline (BB) n=14. Solo el 3 por ciento fueron pacientes Borderline Tuberculoide (BT): 74 por ciento masculino y 26 por ciento femenino. El fenómeno reaccional más frecuente fue del tipo eritema nodoso leproso (ENL). Las proteínas micobacterianas ensayadas fueron: antígenos proteicos crudos totales de Mycobacterium leprae (MlSA), Mycobacterium bovis (MbSA y MbSA de excreción), antígeno proteico de excreción parcialmente purificado con una movilidad relativa de 30 kDa (Ml 30) y proteínas recombinantes de Mycobacterium (Mt70, Mb 65, Ml 36, 28, 18 y 10 kDa) encontrandose que las proteínas recombinantes (Ml10 kDa, Ml 36 kDa) a mayor carga bacilar presentaban una mayor reactividad serológica estadísticamente significativa (p= 0,0051 y 0,050 respectivamente). La proteína de 30 kDa fue predominantemente reconocida por anticuerpos de los pacientes multibacilares. Los resultados demuestran que el promedio de los valores de anticuerpos en pacientes no reaccionales fueron superiores en presencia de proteínas completas (MbSA y MbSA de exc) en comparación con el grupo de pacientes que presentaron fenómenos reaccionales (p=0,000567 y 0,000061 respectivamente) Este mismo comportamiento se observó frente a las proteínas micobacterianas individuales (30 kDa, 10 kDa y 36 kDa). La respuesta proliferativa de los linfocitos T en los pacientes multibacilares reaccionales y no reaccionales frente a las proteínas micobacterianas...


The study was designed for evaluating immunological reactivity to various mycobacterial protein preparations using serological and cell-mediated immunological tests in patients with clinical leprosy signs, predominantly, with the multibacillary forms. All patients were adults with ages between 20 and 30 years. Fifty eight (n= 81) percent corresponded to Lepromatous Leprosy (LL), 29 percent (n= 41) to Borderline Lepromatous Leprosy (BL) and 10 percent (n=41) to Borderline Borderline Leprosy (BB); only 3 percent were Borderline Tuberculoid (BT) patients: 74 percent males and 26 percent females. The most frequent reactional phenomenon was of the Erythema Nodosum (ENL) type. The mycobacterial proteins tested were: total crude Mycobacterium leprae antigens (MISA); Mycobacterium bovis (MbSA and excretion MbSA); partially purified excretion protein antigen, with a 30kDa relative movility (Ml30); and recombinant M. leprae proteins (Mt70, Mb 65, Ml 36, 28, 18 and 10 kDa). Two of the recombinant proteins (Ml10 and Ml 36 kDa) presented a statiscally significant higher serological reactivity, directly related with a larger bacillary load (p= 0.0051 and 0.050 respectively). The 30 kDa protein was predominantly recognized by antibodies from multibacillary patients. Results show that mean antibody values were higher in non reactional patients when tested against complete proteins (MbSA and ex MbSA) when compared with the group of patients who presented reactional phenomena (p= 0.000567 and 0.000061, respectively). Comparing reactional with non reactional patients, it was seen that mean antibody values against complete proteins (MbSA and ex MbSA) were higher in non reactional individuals (p= 0.000567 and 0.000061, respectively). This same behavior occurred towards individual mycobacterial proteins (30, 10 and 36 kDa). The T lymphocyte prolypherative response in reactional and non reactional patients towards mycobacterial proteins (MlSA, Ml 10 kDa, MbSA...


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Proteínas de Bactérias , Hanseníase/imunologia , Proliferação de Células , Sorologia/métodos
6.
Invest Clin ; 51(3): 325-40, 2010 Sep.
Artigo em Espanhol | MEDLINE | ID: mdl-21305770

RESUMO

The study was designed for evaluating immunological reactivity to various mycobacterial protein preparations using serological and cell-mediated immunological tests in patients with clinical leprosy signs, predominantly, with the multibacillary forms. All patients were adults with ages between 20 and 30 years. Fifty eight (n = 81) percent corresponded to Lepromatous Leprosy (LL), 29% (n = 41) to Borderline Lepromatous Leprosy (BL) and 10% (n = 41) to Borderline Borderline Leprosy (BB); only 3% were Borderline Tuberculoid (BT) patients: 74% males and 26% females. The most frequent reactional phenomenon was of the Erythema Nodosum (ENL) type. The mycobacterial proteins tested were: total crude Mycobacterium leprae antigens (MISA); Mycobacterium bovis (MbSA and excretion MbSA); partially purified excretion protein antigen, with a 30 kDa relative movility (Ml30); and recombinant M. leprae proteins (Mt70, Mb 65, Ml 36, 28, 18 and 10 kDa). Two of the recombinant proteins (Ml10 and Ml 36 kDa) presented a statiscally significant higher serological reactivity, directly related with a larger bacillary load (p = 0.0051 and 0.050 respectively). The 30 kDa protein was predominantly recognized by antibodies from multibacillary patients. Results show that mean antibody values were higher in non reactional patients when tested against complete proteins (MbSA and ex MbSA) when compared with the group of patients who presented reactional phenomena (p = 0.000567 and 0.000061, respectively). Comparing reactional with non reactional patients, it was seen that mean antibody values against complete proteins (MbSA and ex MbSA) were higher in non reactional individuals (p = 0.000567 and 0.000061, respectively). This same behavior occurred towards individual mycobacterial proteins (30, 10 and 36 kDa). The T lymphocyte prolypherative response in reactional and non reactional patients towards mycobacterial proteins (MlSA, Ml 10 kDa, MbSA, ex MbSA) was negative.


Assuntos
Proteínas de Bactérias/imunologia , Imunidade Celular , Hanseníase/sangue , Hanseníase/imunologia , Mycobacterium lepraemurium/imunologia , Adulto , Feminino , Humanos , Masculino , Testes Sorológicos , Adulto Jovem
7.
Invest. clín ; 50(4): 513-527, dic. 2009. ilus
Artigo em Espanhol | LILACS | ID: lil-574435

RESUMO

La enfermedad de Hansen presenta un amplio espectro de manifestaciones clínicas e histopatológicas, las cuales son un reflejo de la naturaleza de la respuesta inmunológica del individuo ante diversos componentes del Mycobacterium leprae. El sistema inmunológico, integrado por la existencia de una inmunidad innata y adaptativa, ofrece protección frente a infecciones de diversas etiologías, entre ellas las bacterianas. Por supuesto las bacterias han logrado desarrollar múltiples estrategias para evadir las defensas del hospedador, que se basan en mecanismos algunos muy complejos y otros más simples, pero con una sola finalidad de “resistir” el ataque del hospedador y lograr sobrevivir. Estudios realizados en la enfermedad de Hansen han podido determinar los diferentes componentes que puedan estar actuando tanto en la inmunidad innata cómo en la adquirida. En este trabajo se trata de resumir algunos estudios recientes en la enfermedad de Hansen con mayor énfasis en el área de inmunología, sin dejar de considerar que toda enfermedad debe estar muy ligada a otros aspectos tan igual de importantes cómo son los sociales, ambientales y otros de muy difícil resolución en un laboratorio.


Hansen’s disease presents a wide spectrum of clinical and histopathological manifestations that reflect the nature of the immunological response of the host towards diverse Mycobacterium leprae components. The immunological system, composed by both innate and adaptive immunology, offers protection towards infections of various etiologies, among them bacterial. Bacteria, of course, have developed multiple strategies for evading host defenses, based on either very complex or simple mechanisms, but with a single purpose: to “resist” host attacks and to be able to survive. We have tried to summarize some recent studies in Hansen’s disease, with more emphasis in the inmunology area. We think that in the future, all illnesses should also be very strongly related to other important aspects such as the social, environmental and economic, and whose development is not solved in a laboratory.


Assuntos
Humanos , Masculino , Feminino , Citocinas , Imunidade Inata , Imunidade Materno-Adquirida , Imunidade nas Mucosas , Hanseníase , Modelos Genéticos
8.
Invest Clin ; 50(4): 513-27, 2009 Dec.
Artigo em Espanhol | MEDLINE | ID: mdl-20306725

RESUMO

Hansen's disease presents a wide spectrum of clinical and histopathological manifestations that reflect the nature of the immunological response of the host towards diverse Mycobacterium leprae components. The immunological system, composed by both innate and adaptive immunology, offers protection towards infections of various etiologies, among them bacterial. Bacteria, of course, have developed multiple strategies for evading host defenses, based on either very complex or simple mechanisms, but with a single purpose: to "resist" host attacks and to be able to survive. We have tried to summarize some recent studies in Hansen's disease, with more emphasis in the inmunology area. We think that in the future, all illnesses should also be very strongly related to other important aspects such as the social, environmental and economic, and whose development is not solved in a laboratory.


Assuntos
Hanseníase/imunologia , Imunidade Adaptativa/genética , Citocinas/imunologia , Humanos , Imunidade Celular
9.
Invest Clin ; 46(4): 381-9, 2005 Dec.
Artigo em Espanhol | MEDLINE | ID: mdl-16353545

RESUMO

The crucial clinical problem in leprosy is represented by episodes of intense inflammation that produce nerve damage. When Mycobacterium leprae has been eliminated by means of antibiotics, the death of the bacteria is not a complete solution to the damage caused in nerves. Two of the more frequent immunopathological phenomena in Hansen's disease are Type I, reactions, known as Reversal Reactions (RR), and Type II reactions, of which the most frequent and well known are those called Erythema Nodosum Leprosum (ENL). Type II reactions have been defined as an immunologic complication in multibacillary patients. Both types of reactions are accompanied mainly by the increase of pro-inflammatory cytokines TNF-alpha, IL-1, IL-2, IL-4, IL-6, IL-8, INF-gamma, IL-10, IL-12, among others. In a retrospective analysis of a population of 150 patients of the Central Service of Dermatology, Institute of Biomedicine, where these patients were subjected to Multidrug Therapy (MDT) and MDT + inmunotherapy (IMT), both groups presented type II reactions, but the group that additionally received inmunotherapy also presented type I reactions. In the group of patients that presented ENL, it appeared to be associated with the large amount of bacilli in their lesions.


Assuntos
Hanseníase/imunologia , Humanos , Hanseníase/tratamento farmacológico
10.
Invest. clín ; 46(4): 381-389, dec. 2005. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-419605

RESUMO

El problema clínico crucial en la lepra son los episodios de inflamación aguda que conllevan a daño de los nervios. Aun cuando el Mycobacterium leprae ha sido eliminado mediante el uso de antibióticos, la muerte de la bacteria no es una solución completa al daño ocasionado en los nervios. Dos de los fenómenos inmunopatológicos más frecuentes son: Reacciones tipo I conocidas como reacciones de reversión (RR) y las Reacciones tipo II, como eritema nodoso leproso (ENL). Estas reacciones tipo II se han definido como: una complicación inmunológica en los pacientes multibacilares. Ambos tipos de reacciones están acompañadas por el incremento de citocinas pro-inflamatorias principalmente TNF-a, IL-1, IL-2, IL-4, IL-6, IL-8, INF-g, IL-10, IL-12, entre otras. En un análisis retrospectivo realizado en una población de 150 pacientes del Servicio Central de Dermatología del Instituto de Biomedicina sometidos a terapia multidroga (PQT) y PQT + inmunoterapia, ambos grupos presentaron fenómenos reaccionales tipo II, sólo el grupo que adicionalmente recibió inmunoterapia presentó además reacciones del tipo I. El grupo de pacientes que presentaron ENL estuvo asociado con presencia de gran cantidad de bacilos en las lesiones


Assuntos
Humanos , Masculino , Feminino , Alergia e Imunologia , Doença Granulomatosa Crônica , Hanseníase , Mycobacterium leprae , Venezuela
11.
Science ; 308(5724): 1040-2, 2005 May 13.
Artigo em Inglês | MEDLINE | ID: mdl-15894530

RESUMO

Leprosy, a chronic human disease with potentially debilitating neurological consequences, results from infection with Mycobacterium leprae. This unculturable pathogen has undergone extensive reductive evolution, with half of its genome now occupied by pseudogenes. Using comparative genomics, we demonstrated that all extant cases of leprosy are attributable to a single clone whose dissemination worldwide can be retraced from analysis of very rare single-nucleotide polymorphisms. The disease seems to have originated in Eastern Africa or the Near East and spread with successive human migrations. Europeans or North Africans introduced leprosy into West Africa and the Americas within the past 500 years.


Assuntos
Emigração e Imigração , Hanseníase/história , Mycobacterium leprae/genética , África/epidemiologia , América/epidemiologia , Ásia/epidemiologia , Evolução Biológica , Europa (Continente)/epidemiologia , Genes Bacterianos , Genoma Bacteriano , História do Século XVIII , História do Século XIX , História Antiga , História Medieval , Humanos , Sequências Repetitivas Dispersas , Hanseníase/epidemiologia , Hanseníase/microbiologia , Hanseníase/transmissão , Repetições Minissatélites , Mycobacterium leprae/classificação , Análise de Sequência com Séries de Oligonucleotídeos , Polimorfismo de Nucleotídeo Único , Dinâmica Populacional , Pseudogenes , Análise de Sequência de DNA
13.
s.l; s.n; 2005. 3 p. tab, graf, mapas.
Não convencional em Inglês | SES-SP, HANSEN, SESSP-ILSLPROD, SES-SP, SESSP-ILSLACERVO, SES-SP | ID: biblio-1097746

RESUMO

Leprosy, a chronic human disease with potentially debilitating neurological consequences, results from infection with Mycobacterium leprae. This unculturable pathogen has undergone extensive reductive evolution, with half of its genome now occupied by pseudogenes. Using comparative genomics, we demonstrated that all extant cases of leprosy are attributable to a single clone whose dissemination worldwide can be retraced from analysis of very rare single-nucleotide polymorphisms. The disease seems to have originated in Eastern Africa or the Near East and spread with successive human migrations. Europeans or North Africans introduced leprosy into West Africa and the Americas within the past 500 years.


Assuntos
Humanos , História Antiga , História Medieval , História do Século XVIII , História do Século XIX , Ásia/epidemiologia , América/epidemiologia , Pseudogenes , Genoma Bacteriano , Análise de Sequência com Séries de Oligonucleotídeos , Polimorfismo de Nucleotídeo Único , África/epidemiologia , Emigração e Imigração , Europa (Continente)/epidemiologia , Genes Bacterianos , Hanseníase/história , Hanseníase/microbiologia , Hanseníase/transmissão , Hanseníase/epidemiologia , Mycobacterium leprae/classificação , Mycobacterium leprae/genética
14.
Invest Clin ; 44(2): 129-36, 2003 Jun.
Artigo em Espanhol | MEDLINE | ID: mdl-12815843

RESUMO

The word "reaction" is used in leprosy to describe signs and symptoms of acute inflammation. Type II reactions, including erythema nodosum leprosum (ENL) occur in the multibacillary forms of Hansen's disease. Nitric oxide (NO) could play a role in the response of the host, where a high NO production would be involved in acute inflammatory processes. In this paper we evaluate NO production in serum and in the supernatants of mononuclear cell cultures (MNCC), measured indirectly by Griess' method. The results obtained in serum showed that 52% of patients with ENL (15/29) had a production over 30 microM, distributed as follows: 8/15 had a mean concentration of 36.38 +/- ?5.71 microM; 1/15, 70.5 microM and 6/15 had a mean concentration greater than 100 microM (205.97 +/- 5 microM). Forty eight percent presented nitrite and nitrate levels lower than 30 microM (18.93 +/- 6.15). Only supernatants of mononuclear cell cultures from ENL patients collected at 120 hours of incubation presented NO production levels higher than 10 microM +/- 6.53, as compared with the supernatants from the stable polar forms of the disease (lepromatous leprosy and tuberculoid leprosy), where values were 2.52 microM +/- 1.18 and 2.69 microM +/- 1.07, respectively. These preliminary results show a different metabolic activity in the group of patients with Type II reaction state (ENL).


Assuntos
Hanseníase/diagnóstico , Leucócitos Mononucleares/metabolismo , Óxido Nítrico/sangue , Adulto , Células Cultivadas , Eritema Nodoso/diagnóstico , Feminino , Humanos , Hanseníase/sangue , Hanseníase Virchowiana/diagnóstico , Masculino , Pessoa de Meia-Idade , Nitratos/sangue , Nitritos/sangue
16.
Invest. clín ; 44(2): 129-136, jun. 2003. tab
Artigo em Espanhol | LILACS | ID: lil-399727

RESUMO

El término "reacción" es usado en lepra para describir síntomas y signos de inflamación aguda. En la forma multibacilar de la enfermedad se producen reacciones tipo II, es decir, eritema nodoso lepromatoso (ENL). El óxido nítrico (ON) podría jugar un papel en la respuesta de huésped, donde la producción elevada de ON estaría involucrada en cuadros inflamatorios agudos. En este trabajo se evaluá la producción de ON en suero y en sobrenadantes de cultivos de células mononucleares (CMN). El ON fue medido indirectamente por el método de Griess. En suero, el 52 por ciento de los pacientes con ENL (15/29) presentó niveles de nitritos/nitratos mayores de 30 µM; así 8/15 presentaron una concentración de 36,38 ± 5,71 µM; 1/15 de 70,5 µM y 6/15 mayor de 100 µM (205,97 ± 5 µM). En concordancia con estos resultados, se encontró que sólo los sobrenadantes de cultivos de células mononucleares de los pacientes con ENL colectados a las 120 horas de incubación presentaron niveles significativamente elevados de nitritos/nitratos (10 µM ± 6,53), en comparación con los sobrenadantes de los polos estables de la enfermedad, lepra lepromatosa y lepra tuberculoide, cuyos valores fueron 2,52 µM ± 1,18 y 2,69 µM ± 1,07, respectivamente. Los resultados muestran niveles relativamente encrementados de nitritos/nitratros en el grupo de pacientes con estado reaccional tipo II (ENL), lo cual sugiere la participación de la iNOS en este grupo


Assuntos
Humanos , Eritema Nodoso , Hanseníase , Nitratos , Nitritos , Óxido Nítrico/administração & dosagem , Óxido Nítrico/efeitos adversos , Óxido Nítrico , Medicina , Venezuela
18.
Int. j. lepr. other mycobact. dis ; 70(4): 260-268, Dec., 2002. ilus, tab, graf
Artigo em Inglês | SES-SP, HANSEN, SESSP-ILSLACERVO, SES-SP | ID: biblio-1227122

RESUMO

Proteases are well-recognized as virulence factors in different pathologies, resulting in tissue damage potential. Despite efforts over the past few years to identify mycobacterial protein antigens, there is little information regarding the role of mycobacterial proteinase activities. In this study, by zymography techniques, we have detected and partially studied some biochemical properties of Mycobacterium bovis proteases, such as pH dependency of activity and susceptibility to classical proteinase inhibitors. We observed optimal proteolytic activity at pH 8. Some proteinases were inhibited by classic inhibitors of serine proteases, such as PMSF, AEBSF, and 3-4 DCI. In some AEBSF pre-treated preparations we observed residual gelatinase activity in Rf 0.32. This gelatinase was stimulated by Zn2+ and inhibited by OPA (1 mM). This last effect was reversed by exposure to equimolar quantitative OPA/Zn+2 (1 mM/1 mM). These results suggest the existence of serine proteinase and metalloproteinase types in protein extracts of Mycobacterium bovis.


Assuntos
Gelatinases/biossíntese , Gelatinases/fisiologia , Gelatinases/genética , Gelatinases/imunologia , Mycobacterium bovis/fisiologia , Mycobacterium bovis/genética
19.
Rev Panam Salud Publica ; 12(1): 1-4, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12202018

RESUMO

As part of its 100th-anniversary celebration, the Pan American Health Organization has named 12 persons as "Public Health Heroes of the Americas" in recognition of their noteworthy contributions to public health in the Region of the Americas. Over the course of this year, the Revista Panamericana de Salud Pública/Pan American Journal of Public Health will be carrying pieces written by or about these heroes. Como parte de la celebración de su Centenario, la Organización Panamericana de la Salud (OPS) ha distinguido con el título de Héroes de la Salud Pública a 12 personalidades que se han destacado por su valiosa contribución a la salud en el continente americano. A lo largo de este año, la Revista Panamericana de Salud Pública/Pan American Journal of Public Health publicará una serie de escritos de los mismos galardonados o acerca de ellos.


Assuntos
Hanseníase/epidemiologia , Hanseníase/prevenção & controle , Animais , Surtos de Doenças/prevenção & controle , Humanos , Leishmania/imunologia , Vacinas Sintéticas/imunologia , Vacinas Sintéticas/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA